non-invasive jawline wrinkles treatment post-glp-1 GLP-1s and Rapid Facial Aging: Aesthetic Solutions Fixing “Ozempic Face”: Addressing Facial
Description
The development of GLP-1 receptor agonists for type 2 diabetes was contextualised within the broader research landscape, including orally bioavailable agonists, allosteric modulators, and unimolecular multi-agonists all of which use the native GLP-1 receptor as their primary target
Global Reach and Expanding Indications Though currently approved for type 2 diabetes, Tirzepatide is undergoing additional studies for obesity treatment in non-diabetic individuals, as well as cardiovascular outcome trials
Signs of significant dehydration despite oral rehydration efforts
GLP-1
& Bertone, A
23(9): p
